242 related articles for article (PubMed ID: 33035179)
1. Mid-Term Clinical Outcomes Following Percutaneous Mitral Valve Edge-to-Edge Repair.
Demir OM; Ruffo MM; Godino C; Ancona M; Ancona F; Stella S; Munafó AR; Sisinni A; Agricola E; Colombo A; Chieffo A; Montorfano M
J Invasive Cardiol; 2020 Dec; 32(12):E313-E320. PubMed ID: 33035179
[TBL] [Abstract][Full Text] [Related]
2. Predictors of rehospitalization after percutaneous edge-to-edge mitral valve repair by MitraClip implantation.
Keßler M; Seeger J; Muche R; Wöhrle J; Rottbauer W; Markovic S
Eur J Heart Fail; 2019 Feb; 21(2):182-192. PubMed ID: 30178493
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of conventional surgery versus MitraClip® therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience.
Alozie A; Paranskaya L; Westphal B; Kaminski A; Sherif M; Sindt M; Kische S; Schubert J; Diedrich D; Ince H; Steinhoff G; Öner A
BMC Cardiovasc Disord; 2017 Mar; 17(1):85. PubMed ID: 28320316
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients With Primary Mitral Regurgitation Who Are Candidates for Surgery: Design and Rationale of the REPAIR MR Trial.
McCarthy PM; Whisenant B; Asgar AW; Ailawadi G; Hermiller J; Williams M; Morse A; Rinaldi M; Grayburn P; Thomas JD; Martin R; Asch FM; Shu Y; Sundareswaran K; Moat N; Kar S
J Am Heart Assoc; 2023 Feb; 12(4):e027504. PubMed ID: 36752231
[TBL] [Abstract][Full Text] [Related]
5. MitraClip implantation for high risk patients with severe mitral regurgitation: the Sheba experience.
Koifman E; Fefer P; Hay I; Feinberg M; Maor E; Guetta V
Isr Med Assoc J; 2014 Feb; 16(2):91-5. PubMed ID: 24645227
[TBL] [Abstract][Full Text] [Related]
6. The MitraClip Procedure in Patients With Moderate Resting but Severe Exercise-Induced Mitral Regurgitation.
Curio J; Tarar W; Al-Hindwan HSA; Neumann R; Berger C; Hoting MO; Kasner M; Lendlein A; Landmesser U; Reinthaler M
J Invasive Cardiol; 2020 Jan; 32(1):E1-E8. PubMed ID: 31893503
[TBL] [Abstract][Full Text] [Related]
7. Outcome comparison of mitral valve surgery and MitraClip therapy in patients with severely reduced left ventricular dysfunction.
Gyoten T; Schenk S; Rochor K; Herwig V; Harnath A; Grimmig O; Just S; Fritzsche D; Messroghli D
ESC Heart Fail; 2020 Aug; 7(4):1781-1790. PubMed ID: 32445540
[TBL] [Abstract][Full Text] [Related]
8. One-Year Outcomes After MitraClip for Functional Mitral Regurgitation.
Ailawadi G; Lim DS; Mack MJ; Trento A; Kar S; Grayburn PA; Glower DD; Wang A; Foster E; Qasim A; Weissman NJ; Ellis J; Crosson L; Fan F; Kron IL; Pearson PJ; Feldman T;
Circulation; 2019 Jan; 139(1):37-47. PubMed ID: 30586701
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous mitral valve repair in high-risk patients: initial experience with the Mitraclip system in Belgium.
Vandendriessche T; Kotrc M; Tijskens M; Bartunek J; Delesie M; Paelinck BP; De Bock D; Penicka M; Stockman B; De Maeyer C; Vrints C; Vanderheyden M; Claeys MJ
Acta Cardiol; 2014 Jun; 69(3):265-70. PubMed ID: 25029871
[TBL] [Abstract][Full Text] [Related]
10. MitraClip therapy and surgical edge-to-edge repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: mid-term results of a single-centre experience†.
De Bonis M; Taramasso M; Lapenna E; Denti P; La Canna G; Buzzatti N; Pappalardo F; Di Giannuario G; Cioni M; Giacomini A; Alfieri O
Eur J Cardiothorac Surg; 2016 Jan; 49(1):255-62. PubMed ID: 25669650
[TBL] [Abstract][Full Text] [Related]
11. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry.
Attizzani GF; Ohno Y; Capodanno D; Cannata S; Dipasqua F; Immé S; Mangiafico S; Barbanti M; Ministeri M; Cageggi A; Pistritto AM; Giaquinta S; Farruggio S; Chiarandà M; Ronsivalle G; Schnell A; Scandura S; Tamburino C; Capranzano P; Grasso C
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):74-82. PubMed ID: 25499300
[TBL] [Abstract][Full Text] [Related]
12. Predictors for long-term survival after transcatheter edge-to-edge mitral valve repair.
Orban M; Orban M; Lesevic H; Braun D; Deseive S; Sonne C; Hutterer L; Grebmer C; Khandoga A; Pache J; Mehilli J; Schunkert H; Kastrati A; Hagl C; Bauer A; Massberg S; Boekstegers P; Nabauer M; Ott I; Hausleiter J
J Interv Cardiol; 2017 Jun; 30(3):226-233. PubMed ID: 28370526
[TBL] [Abstract][Full Text] [Related]
13. Early Outcomes of 2 Mitral Valve Transcatheter Leaflet Approximation Devices: A Propensity Score-Matched Multicenter Comparison.
Mauri V; Sugiura A; Spieker M; Iliadis C; Horn P; Öztürk C; Besler C; Riebisch M; Al-Hammadi O; Ruf T; Gerçek M; Grothusen C; Mehr M; Becher MU; Mues C; Boeder N; Kreidel F; Friedrichs K; Westenfeld R; Braun D; Baldus S; Rassaf T; Thiele H; Nickenig G; Hausleiter J; Möllmann H; Kelm M; Rudolph V; von Bardeleben RS; Nef HM; Luedike P; Lurz P; Pfister R
JACC Cardiovasc Interv; 2022 Dec; 15(24):2541-2551. PubMed ID: 36543448
[TBL] [Abstract][Full Text] [Related]
14. Single-center five-year outcomes after interventional edge-to-edge repair of the mitral valve.
Öztürk C; Friederich M; Werner N; Nickenig G; Hammerstingl C; Schueler R
Cardiol J; 2021; 28(2):215-222. PubMed ID: 31313274
[TBL] [Abstract][Full Text] [Related]
15. Risk Stratification of Percutaneous Edge-to-Edge Repair by MitraClip in Patients with Mitral Regurgitation.
Tanaka S; Imamura T; Ushijima R; Fukuda N; Ueno H; Kinugawa K
Int Heart J; 2021 Jan; 62(1):112-118. PubMed ID: 33455987
[TBL] [Abstract][Full Text] [Related]
16. Impact of left ventricular systolic dysfunction on the outcomes of percutaneous edge-to-edge mitral valve repair using MitraClip.
Kaneko H; Neuss M; Schau T; Weissenborn J; Butter C
Heart Vessels; 2016 Dec; 31(12):1988-1996. PubMed ID: 26968992
[TBL] [Abstract][Full Text] [Related]
17. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
[TBL] [Abstract][Full Text] [Related]
18. Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction.
Gyoten T; Messroghli D; Schenk S; Rochor K; Grimmig O; Just S; Fritzsche D
Open Heart; 2020; 7(1):e001203. PubMed ID: 32201589
[TBL] [Abstract][Full Text] [Related]
19. Surgical or percutaneous mitral valve repair for secondary mitral regurgitation: comparison of patient characteristics and clinical outcomes.
Conradi L; Treede H; Rudolph V; Graumüller P; Lubos E; Baldus S; Blankenberg S; Reichenspurner H
Eur J Cardiothorac Surg; 2013 Sep; 44(3):490-6; discussion 496. PubMed ID: 23401496
[TBL] [Abstract][Full Text] [Related]
20. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair.
Lim DS; Reynolds MR; Feldman T; Kar S; Herrmann HC; Wang A; Whitlow PL; Gray WA; Grayburn P; Mack MJ; Glower DD
J Am Coll Cardiol; 2014 Jul; 64(2):182-92. PubMed ID: 24184254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
